We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates MAPP Procedures Regarding SGEs Representing Sponsors Before CDER
FDA Updates MAPP Procedures Regarding SGEs Representing Sponsors Before CDER
Clarifying how government- and sponsor-paid experts can sometimes aid sponsors in meetings with FDA, the agency updated its Manual of Policies and Procedures (MAPP) concerning special government employees (SGEs) who represent sponsors before the agency’s Center for Drug Evaluation and Research (CDER).